UNSPSC 51111633: Edatrexate

This classification denotes a folate antagonist and dihydrofolate reductase inhibitor with the molecular formula C22H25N7O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier JT4X6Z1HRR, chemically known as n-(p-(1-((2,4-diamino-6-pteridinyl)methyl)propyl)benzoyl)-l-glutamic acid but generally known as edatrexate, which bears US NIH Compound Identifier 54586. European Medicines Agency schedules Edatrexate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06454MIG.

UNSPSC 51111633 Edatrexate is a Commodity-level code for the pharmaceutical product edatrexate, a methotrexate analog used in oncology and immunosuppressive therapy. State and local governments procure this drug primarily through state Medicaid programs, state correctional health systems, state mental health facilities, and county public health departments that serve low-income or uninsured populations. Purchasing is typically consolidated at the state level through pharmaceutical contracting vehicles, group purchasing organizations (GPOs), or managed Medicaid plans rather than through individual solicitations visible in public procurement channels. The code represents a narrow, specialized pharmaceutical input with limited direct procurement visibility outside state pharmacy and health-system contracting frameworks.

The source provides no recent state or local contract opportunities tagged to this code. Without visible recent solicitations, there is no geographic concentration to characterize, issuing-body pattern to discern, or representative opportunity to name. This reflects the nature of pharmaceutical procurement at the state and local level — most edatrexate contracting flows through standing formulary agreements, GPO master agreements, or state Department of Health / Medicaid standing contracts rather than through open-market RFPs, RFQs, or ITBs. Firms seeking to sell edatrexate to state or local health systems should focus on existing state Medicaid contracts, state correctional health system formularies, and GPO alignment rather than wait for visible bid activity under this code.